TAG:
diagnostic testing
Genetic Testing Almost Accented In Market Place
By Robert Michel | From the Volume V No. 12 – September 8, 1998 Issue
CEO SUMMARY: Advances in molecular and genetic science have generated the first generation of diagnostic assays for clinical use. As these assays reach the public, acceptance is not immediate. Obstacles are many: ethical, cultural, clinical, and economic. Oncormed’s experience during th…
DIANON Shoots At Urocor, Makes Unwelcome Offer
By Robert Michel | From the Volume V No. 12 – September 8, 1998 Issue
CEO SUMMARY: It pays to know your friends. Last month DIANON Systems announced an unsolicited offer to acquire UroCor. The offer, following months of ongoing discussions between the two companies, was clearly unwelcome at UroCor. Both companies are pushing hard to evolve disease managemen…
“July 6, 1998 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume V No. 9 – July 6, 1998 Issue
Last week THE DARK REPORT toured the Framingham, Massachusetts laboratory of Genzyme Genetics, the diagnostic testing division of Genzyme Corporation. It is probably the largest genetics-based diagnostics laboratory organization in the United States. The company’s …
Humana, Inc. Acquired By United Healthcare
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
CEO SUMMARY: Clinical laboratories will see increased concentration of laboratory purchasing as a result of this merger. The combined company will insure 19.2 million people in 48 states. This transaction confirms that consolidation proceeds in all areas of the healthcare industry, despit…
“Disease Management” Firms, Niche Labs Release Financials
By Robert Michel | From the Volume V No. 8 – June 15, 1998 Issue
Two DISEASE MANAGEMENT FIRMS enjoyed strong revenue growth during the first quarter of 1998. UroCor, Inc. and Impath Inc. posted revenue increases of 31% and 49%, respectively, over first quarter 1997. UroCor is the disease management company which serves urologists…
A Fable For Our Times: Lab Industry’s Golden Era
By Robert Michel | From the Volume V No. 6 – May 4, 1998 Issue
CEO SUMMARY: The clinical laboratory industry’s “Golden Era” is gone forever. Replacing it is a healthcare environment best described as “Darwinian.” It is now survival of the fittest, as hospital laboratories and commercial laboratories struggle to reinvent themselves. Case stu…
DIANON Systems Acquires Pathology Lab In Florida
By Robert Michel | From the Volume V No. 3 – March 2, 1998 Issue
CEO SUMMARY: Another national pathology player is betting on Florida. DIANON Systems, Inc.’s purchase of a local pathology laboratory raises the competitive bar in Florida. With AmeriPath and Pathology Service Associates already gearing up to battle for market share, DIANON’s local pr…
AmeriPath, SmithKline, Unilab, IMPATH, LabOne, Prudential/SBCL
By Robert Michel | From the Volume V No. 3 – March 2, 1998 Issue
AMERIPATH REPORTS EARNINGS, NEW PURCHASE AmeriPath, Inc. of Riviera Beach, Florida announced its 1997 financial performance. For the year, company revenues totaled $108.4 million. On February 17, the company also disclosed the acquisition of Anatomic Pathology Associates (A…
SmithKline May Merge With Glaxo Wellcome
By Robert Michel | From the Volume V No. 2 – February 9, 1998 Issue
CEO SUMMARY: Both companies confirm that merger talks are under way. The merger is another example of consolidation within the healthcare industry, and is expected to trigger mergers between other drug companies. Fate of SmithKline’s clinical laboratory division in the merger with Glaxo…
1997’s Top Ten Lab Stories Predict New Directions
By Robert Michel | From the Volume IV No. 18 – December 29, 1997 Issue
CEO SUMMARY: Events during 1997 reveal that the laboratory industry continues to undergo fundamental change. Yet even amidst the industry’s downsizing, selected laboratory organizations continue to flourish. Here is THE DARK REPORT’s annual look at top stories for the year. A careful …
CURRENT ISSUE

Volume XXXII, No. 13 – September 15, 2025
The Dark Report examines a new bill that would reform PAMA and avoid reimbursement rate cuts scheduled for January 2026. Clinical laboratory leaders are urged to make their voices heard in Congress. Also, an expert describes how labs can fix pre-analytical errors and avoid disaster.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized